IntroductionHIV type 1 (HIV-1) Vpu (viral protein U) is an accessory gene exclusive to HIV-1 but not present in HIV-2 and in most SIVs. [1][2][3] Studies in a macaque model have shown that Vpu from subtype B plays a crucial role in massive loss of circulating CD4 ϩ T lymphocytes, 4-6 which can be modulated by replacing it with Vpu from subtype C. 7 The exact mechanism(s) underlying how Vpu makes HIV-1 more pathogenic is only partially understood. 8,9 Vpu is involved in ubiquitination and degradation of antiretroviral restriction factor BM stromal cell Ag 2 (BST-2; also known as tetherin) and surface receptor CD4 through their recruitment to SCF -TrcP (Skp1/Cul1/F-box) ubiquitin ligase (SCF) complex. [10][11][12][13] The key to biologic function of Vpu is the presence of a highly conserved 6-amino acid (DS 52 GNES 56 ) sequence that constitutes the -TrcP (-transducin repeat-containing proteins) binding motif. 14 This motif is constitutively phosphorylated and mediates interaction of Vpu with -TrcP, the substrate recognition subunit of SCF -TrcP complex. Hence, Vpu acts as an adaptor linking its target proteins (CD4 and BST-2) to a host E3 ubiquitin ligase SCF -TrcP complex, which are otherwise not the natural substrates of this complex. However, unlike natural substrates of -TrcP, which are targeted for degradation, Vpu itself is resistant to degradation and can form stable complexes with -TrcP. 15 Thus, expression of constitutively phosphorylated Vpu in infected cells leads to competitive inhibition of ubiquitination and subsequent proteosomal degradation of many natural substrates of SCF -TrcP complex (-catenin, activating transcription factor 4, and I-␣) and results in changes in the profile of cellular proteins that may contribute to cytopathic effects during HIV-1 infection. 9,15,16 The inability to degrade I-␣ and to activate NF- on stimulation with TNF-␣ explains the TNF-␣-sensitive phenotype of Vpu-expressing cells. 9 Interestingly, more recent data suggest that Vpu is also degraded by both -TrcPdependent 17 and -independent pathways, 18 which in turn may have a role in modulating biologic activities of Vpu.The SCF -TrcP ubiquitin ligase complex controls the functions of a wide spectrum of cellular proteins 16,[19][20][21][22] ; many of them are involved in pathways crucial to HIV-1 pathology. Tumor suppressor protein p53 is reported to be a major player involved in HIV-1-induced apoptosis. [23][24][25] p53 protein has been shown to be an important substrate of -TrcP-dependent ubiquitination. Small interfering RNA (siRNA)-mediated depletion of components of SCF -TrcP complex or the expression of a dominant-negative form of -TrcP was shown to enhance the stability of p53 protein and also to activate p53 downstream signaling events. 22 Like most of the natural -TrcP substrates (I-␣, -catenin, p65, and steroid receptor coactivator 3), the I kinase 2 (IKK2/IKK) also phosphorylates p53 at serine 362/366 (Ser362/366) position directing it for -TrcP-mediated ubiquitination in an Mdm-2 ind...